
NanoSomiX and Beckman Coulter Diagnostics have announced plans to collaborate on the development of next-generation immunoassays for neurodegenerative diseases using …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

